Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Europe GmbH

European News

Ranbaxy introducing osteoporosis drug EVISTA® into the Romanian market

Edoxaban - next generation oral anticoagulant under investigation to help prevent stroke in patients

DAIICHI SANKYO and Lilly receive U.S. FDA approval for EFFIENT®

DAIICHI SANKYO awarded the "Best Cardiovascular Pipeline"

Time for change - International Womens Day

DAIICHI SANKYO takes over cardiovascular sales force from Merck Serono in Italy

European Commission Approves EFIENT® (prasugrel)

DAIICHI SANKYO appoints Managing Director for Ireland

Blood pressure goal missed by two thirds of patients